Intermediates in the refolding of ribonuclease at subzero temperatures. 2. Monitoring by inhibitor binding and catalytic activity. 1988

R G Biringer, and C M Austin, and A L Fink
Department of Chemistry, University of California, Santa Cruz 95064.

The kinetics of refolding of ribonuclease A were monitored by the return of catalytic activity and inhibitor binding at -15 degrees C in 35% methanol cryosolvent at pH* 3.0 and 6.0. Catalytic activity was measured with cytidine 2',3'-cyclic monophosphate as substrate; inhibitor binding was determined with the competitive inhibitor cytidine 2'-monophosphate. Biphasic kinetics were observed at pH* 3.0 for both return of catalytic activity and inhibitor binding. At pH* 6.0 the rate of return of catalytic activity was monophasic, whereas that of inhibitor binding was biphasic. For both inhibitor binding and catalytic activity one of the observed rates was pH-dependent. Full return of catalytic activity was obtained at the completion of the refolding process. The observations are interpreted in terms of two parallel pathways of refolding for slow-refolding ribonuclease, with several native-like, partially folded intermediate states on the minor slow-refolding pathway. Of particular note is the presence of at least one such species that has inhibitor-binding capacity but not catalytic activity. This may be rationalized in terms of the known native structure. In addition, an intermediate is postulated which has the incorrect Pro-93 conformation and only partial catalytic activity (42% of the native). The slowest observed transient is attributed to the isomerization of this proline residue and return of full catalytic activity.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D011489 Protein Denaturation Disruption of the non-covalent bonds and/or disulfide bonds responsible for maintaining the three-dimensional shape and activity of the native protein. Denaturation, Protein,Denaturations, Protein,Protein Denaturations
D003563 Cyclic CMP A cyclic nucleotide formed from CYTIDINE TRIPHOSPHATE by the action of cytidylate cyclase. It is a potential cyclic nucleotide intracellular mediator of signal transductions. Cytidine Cyclic-3',5'-Monophosphate,Cyclic CMP, Monosodium Salt,Cytidine Cyclic 3,5 Monophosphate,Cytidine Cyclic Monophosphate,CMP, Cyclic,Cyclic Monophosphate, Cytidine,Cyclic-3',5'-Monophosphate, Cytidine,Cytidine Cyclic 3',5' Monophosphate,Monophosphate, Cytidine Cyclic
D005615 Freezing Liquids transforming into solids by the removal of heat. Melting
D006863 Hydrogen-Ion Concentration The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH pH,Concentration, Hydrogen-Ion,Concentrations, Hydrogen-Ion,Hydrogen Ion Concentration,Hydrogen-Ion Concentrations
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D012259 Ribonuclease, Pancreatic An enzyme that catalyzes the endonucleolytic cleavage of pancreatic ribonucleic acids to 3'-phosphomono- and oligonucleotides ending in cytidylic or uridylic acids with 2',3'-cyclic phosphate intermediates. EC 3.1.27.5. RNase A,Ribonuclease A,Pancreatic RNase,RNase I,Ribonuclease (Pancreatic),Ribonuclease I,Pancreatic Ribonuclease,RNase, Pancreatic

Related Publications

R G Biringer, and C M Austin, and A L Fink
January 1988, Biochemistry,
R G Biringer, and C M Austin, and A L Fink
February 1988, FEBS letters,
R G Biringer, and C M Austin, and A L Fink
November 2001, FEBS letters,
R G Biringer, and C M Austin, and A L Fink
April 1979, Journal of molecular biology,
R G Biringer, and C M Austin, and A L Fink
April 2021, Journal of assisted reproduction and genetics,
R G Biringer, and C M Austin, and A L Fink
May 1968, Applied microbiology,
R G Biringer, and C M Austin, and A L Fink
April 1982, The Journal of biological chemistry,
R G Biringer, and C M Austin, and A L Fink
November 1991, European journal of biochemistry,
R G Biringer, and C M Austin, and A L Fink
March 1967, Applied microbiology,
Copied contents to your clipboard!